The objectives of the European Society of Veterinary Pathology are to promote the scientific work of veterinary surgeons and physicians active in the areas of functional and morphologic pathology of animals, as well as that of other interested natural scientists, by means of organising scientific post-graduate training, conferences and meetings.
Learn more about the history, mission and vision of the ESVP.
On the Inside:
You can also download this newsletter as PDF or Word Document
Annual seminar of the French Society of Veterinary Pathology
16th- 17th November 2018
Ecole Vétérinaire D'Alfort
Amphithéâtre Brion
Guest speakers: Dr Rachel Ciancolo (Ohio State University, USA), Dr Rachel Lavoué (National Veterinary School of Toulouse, France)
Boehringer Ingelheim RCV Vienna is home to Boehringer Ingelheim’s dedicated drug discovery center for innovative cancer medicines. A team of more than 200 scientists and technicians, combining their expertise in cancer biology and genomics,pharmacology, medicinal chemistry, structural research, high-throughput screening and discovery ADME, drive our efforts to identify novel medication for the treatment of cancer. In the Department of Pharmacology we are currently looking for a highly motivated and result oriented scientist (m/f) to serve as a Molecular Pathology Associate/Principal Scientist in the Biomarker and Translational Research Group in Oncology.
Saturday 3rd & Sunday 4th of November 2018
Leahurst Campus, CH64 7TE
Dear colleagues,
There is still time to register for the 16th ESTP congress in Copenhagen, September 11-14 2018.
We have put together an interesting program with the title “Adipose tissue and central nervous system in metabolic and neurodegenerative diseases: Biology, toxicologic pathology and investigative techniques”.
Residency in Veterinary Pathology / Lecturer in Veterinary Pathology in the Department of Histology and Pathology, Veterinary school of Toulouse, France
The Biomarkers and Biogenesis of Extracellular Vesicles Workshop
Padova, Italy 29-31 August 2018
The most recent advancements in the EV field will be discussed and reviewed together with a team of world renowned scientists and experts from the EV field.
We are seeking a veterinarian to undertake a postgraduate research project on reptarenaviruses and the diagnosis of Boid Inclusion Body Disease (BIBD). The project will focus on molecular biological and in vitro studies. The position is available from 1st September 2018, initially for 12 months.
Due to continued and increasing demands for our services, we are again looking for an enthusiastic, personable and talented veterinary anatomic pathologist.
Bridge Pathology Ltd. is a veterinary diagnostic histopathology and immunohistochemistry company set in a lovely part of Bristol, UK, dedicated to the provision of the very highest quality diagnostic surgical pathology services to the veterinary community. You will work in a highly collegial and friendly atmosphere alongside an international group of nine enthusiastic and hugely talented anatomic pathologists, and a tremendously supportive and smart technical and administrative team.
Bayer is a global enterprise with core competencies in the Life Science Fields of health care and agriculture. Its products and services are designed to benefit people and improve their quality of life. At Bayer you have the opportunity to be part of a culture where we value passion of our employees to innovate and give them the power to change.
Joint with European Congress of the ESVP/ECVP, University of Agricultural Sciences and Veterinary Medicine
Cluj-Napoca, Romania, September 6th 2018
Any questions contact Barbara McMahill, ISVD Vice President (Enable JavaScript to view this email address.)
You'll find application information at:
http://www.unipd.it/en/research/doctoral-degrees-phd-programmes/phd-programmes-calls-and-admissions
The information about the specific project are here:
http://www.dottorato.veterinaria.unipd.it/comparative-pathology-cancer
Deadline: 26th of June 2018
Contact: Valentina Zappulli (Enable JavaScript to view this email address.)
Your main task is to provide toxicology and pathology expertise and mechanistic understanding in the interpretation of nonclinical findings, and their relevance to humans. Histopathological evaluation and peer review of regulatory and exploratory toxicological and efficacy studies, including interpretation of clinical pathology results, is also essential part of your job. You serve also as a nonclinical safety expert in multifunctional project teams on discovery and development projects and build up the holistic safety knowledge of the molecule from the beginning to the end of projects. You design and oversee execution of nonclinical toxicology studies and programs for small and large molecules during discovery and development phase.
